The nature and composition of 15-deoxy-Δ12,14PGJ2

Prostaglandins and Other Lipid Mediators

Volumn 62, Issue 1, 2000, Pages 15-21

  Maxey, Kirk M ^a   Hessler, Edward ^b   MacDonald, James ^a   Hitchingham, Linda ^a  

^a Cayman Chemical Company   (United States)

^b Bridge Organics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12 PROSTAGLANDIN J2; CELL NUCLEUS RECEPTOR; DELTA12 PROSTAGLANDIN J2; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN J2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; DRUG DECOMPOSITION; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; ISOMER; MASS SPECTROMETRY; NONHUMAN; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; HUMANS; PROSTAGLANDIN D2;

EID: 0033880815     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(00)00072-1     Document Type: Article

References (19)

1. 2 in a human female with mastocytosis. Prostaglandins. 30:1985;383-400.
2. 2 in a normal human male volunteer. J Biol Chem. 260:1985;13172-13180.
3. 2 in the monkey. J Biol Chem. 254:1979;4152-4163.
4. 2. Biochemistry. 29:1990;3760-3765.
5. 2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Cancer Res. 50:1990;1879-1885.
6. Chen Y., Morrow J.D., Roberts L.J. II. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J Biol Chem. 274:1999;10863-10868.
7. 2. Identification of products formed in vitro. J Biol Chem. 258:1983;11713-11718.
8. 2 formed in human plasma. Proc Natl Acad Sci USA. 81:1984;1317-1321.
9. 2 in human urine. J Biol Chem. 263:1988;16619-16625.
10. Bundy G.L., Morton D.R., Peterson D.C., Nishizawa E.E., Miller W.L. Synthesis and platelet aggregation inhibiting activity of prostaglandin D analogues. J Med Chem. 26:1983;790-799.
11. 2 metabolite binds peroxisome proliferator-activated receptorγ and promotes adipocyte differentiation. Cell. 83:1995;813-819.
12. 2 is a ligand for the adipocyte determination factor PPARγ Cell. 83:1995;803-812.
13. Thieringer R., Fenyk-Melody J.E., Le Grand C.B., et al. Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo. J Immunol. 64:2000;1046-1054.
14. 2 integrin-dependent oxidative burst involvement of a mechanism distinct from peroxisome proliferator-activated receptor γ ligation . J Immunol. 163:1999;6187-6192.
15. Murphy R.C., Hammarström S., Samuelsson B. Leukotriene C a slow-reacting substance from murine mastocytoma cells . Proc Natl Acad Sci USA. 76:1979;4275-4279.
16. Moncada S., Gryglewski R., Bunting S., Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 263:1976;663-665.
17. Hamberg M., Svensson J., Samuelsson B. Thromboxanes a new group of biologically active compounds derived from prostaglandin endoperoxides . Proc Natl Acad Sci USA. 72:1975;2994-2998.
18. 1990 Cayman Chemical Company catalog.
19. NMR studies performed and interpreted by Dr. E. Hessler.